Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Nov 4:S0885-3924(25)00924-8.
doi: 10.1016/j.jpainsymman.2025.10.031. Online ahead of print.

Elastomeric pumps for continuous subcutaneous infusion of symptom control medication on discharge

Affiliations

Elastomeric pumps for continuous subcutaneous infusion of symptom control medication on discharge

Stephanie Gover et al. J Pain Symptom Manage. .

Abstract

Background: Maintaining continuous subcutaneous infusion (CSCI) of symptom control medication is difficult when discharging palliative and end of life (EoL) patients.

Objectives: To determine the feasibility of using a single use elastomeric pump (EP) to deliver CSCI medication for 24 hours, as an alternative to syringe drivers (SDs) at discharge.

Methods: Palliative care inpatients on CSCIs leaving a tertiary hospital were prescribed an EP for day leave or discharge. We collected retrospective data over 12 months on the number of EPs administered, drug prescription, and adverse events. Hospital savings in terms of bed-days and loss of hospital pumps were extrapolated from this.

Results: 107 EPs were administered to patients leaving hospital without issue. 16 patients were given 2 EPs to facilitate administration of incompatible drugs. Extrapolated costs indicate £59,060 was saved over 12-months.

Conclusions: EPs are a safe, effective, and cost-saving method to deliver CSCI medication for palliative care and EoL patients leaving hospital.

Keywords: Palliative; discharge; elastomeric pump; symptom control; syringe driver.

PubMed Disclaimer

Conflict of interest statement

DISCLOSURES No conflicts of interest were reported.

LinkOut - more resources